SCHEMBL25609123

SCHEMBL25609123

COC(=O)CC(CC(=O)OC)N(Cc1ccc(OC)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 1/20 0.43
▸ CACNA1B Q00975 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ MMP1 P03956 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ LDHA P00338 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25609121 0.84 ALDH1A1 (0.41) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL24291657 0.81 ALDH1A1 (0.43) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL29765190 0.80 HDAC3 (0.40) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL23995941 0.80 HDAC3 (0.40) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL8893537 0.78 LDHA (0.44) NR1D1TDP1ALDH1A1HTTMEN1
SCHEMBL20578054 0.77 CACNA1B (0.42) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL20578055 0.77 CACNA1B (0.42) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL25448644 0.77 HTT (0.49) NR1D1TDP1ALDH1A1HTTMEN1
SCHEMBL5494081 0.77 LDHA (0.43) NR1D1CACNA1BTDP1ALDH1A1HTT
SCHEMBL11148899 0.77 LDHA (0.43) NR1D1CACNA1BTDP1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718610-B2 Compounds containing benzosultam MEDSHINE DISCOVERY INC. (CN) 2023-08-08 — — US disclosed
US-11718610-B2 Compounds containing benzosultam MEDSHINE DISCOVERY INC. (CN) 2023-08-08 — — US disclosed
US-20230183230-A1 COMPOUNDS CONTAINING BENZOSULTAM SUZHOU GENHOUSE BIO CO., LTD. (CN) 2023-06-15 — — US disclosed
US-20230183230-A1 COMPOUNDS CONTAINING BENZOSULTAM SUZHOU GENHOUSE BIO CO., LTD. (CN) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183230-A1 COMPOUNDS CONTAINING BENZOSULTAM TBXA2R, TBXAS1, SULT2A1 NR1D1 840/4885CACNA1B 827/4885TDP1 3865/4885
US-11718610-B2 Compounds containing benzosultam TBXA2R, TBXAS1, SULT2A1 NR1D1 840/4885CACNA1B 827/4885TDP1 3865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback